Literature DB >> 31163289

Calcium channels and cancer stem cells.

Debbie O'Reilly1, Paul Buchanan2.   

Abstract

Cancer stem cells (CSC's) have emerged as a key area of investigation due to associations with cancer development and treatment resistance, related to their ability to remain quiescent, self-renew and terminally differentiate. Targeting CSC's in addition to the tumour bulk could ensure complete removal of the cancer, lessening the risk of relapse and improving patient survival. Understanding the mechanisms supporting the functions of CSC's is essential to highlight targets for the development of therapeutic strategies. Changes in intracellular calcium through calcium channel activity is fundamental for integral cellular processes such as proliferation, migration, differentiation and survival in a range of cell types, under both normal and pathological conditions. Here in we highlight how calcium channels represent a key mechanism involved in CSC function. It is clear that expression and or function of a number of channels involved in calcium entry and intracellular store release are altered in CSC's. Correlating with aberrant proliferation, self-renewal and differentiation, which in turn promoted cancer progression and treatment resistance. Research outlined has demonstrated that targeting altered calcium channels in CSC populations can reduce their stem properties and induce terminal differentiation, sensitising them to existing cancer treatments. Overall this highlights calcium channels as emerging novel targets for CSC therapies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium; Calcium channels; Cancer stem cells; Treatment resistance; Tumour relapse

Year:  2019        PMID: 31163289     DOI: 10.1016/j.ceca.2019.05.006

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  5 in total

1.  Inhibition of PKCε induces primordial germ cell reprogramming into pluripotency by HIF1&2 upregulation and histone acetylation.

Authors:  Adrian Moratilla; Diego Sainz de la Maza; Marta Cadenas Martin; Pilar López-Iglesias; Pilar González-Peramato; Maria P De Miguel
Journal:  Am J Stem Cells       Date:  2021-02-15

2.  Calsequestrin 2 overexpression in breast cancer increases tumorigenesis and metastasis by modulating the tumor microenvironment.

Authors:  Ju Hee Kim; Eun-Shin Lee; Jihui Yun; Han Suk Ryu; Hong Kyu Kim; Young Wook Ju; Kwangsoo Kim; Jong-Il Kim; Hyeong-Gon Moon
Journal:  Mol Oncol       Date:  2021-11-14       Impact factor: 6.603

Review 3.  Put in a "Ca2+ll" to Acute Myeloid Leukemia.

Authors:  Clara Lewuillon; Marie-Océane Laguillaumie; Bruno Quesnel; Thierry Idziorek; Yasmine Touil; Loïc Lemonnier
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

4.  Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel.

Authors:  Neema Kumari; Pravin Shankar Giri; Subha Narayan Rath
Journal:  Cancer Drug Resist       Date:  2021-11-14

5.  Unraveled roles of Cav1.2 in proliferation and stemness of ameloblastoma.

Authors:  Shujin Li; Dong-Joon Lee; Hyun-Yi Kim; Jun-Young Kim; Young-Soo Jung; Han-Sung Jung
Journal:  Cell Biosci       Date:  2022-09-03       Impact factor: 9.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.